Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120290) titled 'A single-center, observational, cohort study to evaluate the real-world efficacy and safety of faroxizumab injection in patients with newly diagnosed diabetic macular edema' on March 11.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Condition:
Diabetic macular edema
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-11
Target Sample Size: Diabetic macular edema observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...